{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:40Z","timestamp":1790916820441,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":201,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Cancer Foundation Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Finnish Cultural Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005424","name":"Southwest Finland Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["965,193"],"award-info":[{"award-number":["965,193"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005609","name":"University of Turku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007634","name":"Ida Montinin Saatio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101332","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:27:00Z","timestamp":1785338820000},"page":"101332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["High expression of the multifunctional proto-oncogene BMI1 predicts poor outcome in high-grade serous carcinoma"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1650-0918","authenticated-orcid":false,"given":"Pia","family":"Roering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4382-0751","authenticated-orcid":false,"given":"Lilla","family":"Csellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona","family":"Raineva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kia","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu","family":"H\u00e4nninen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Ray","family":"Laury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanina D.","family":"Heuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Carp\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101332_bib0001","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ctarc.2026.101332_bib0002","doi-asserted-by":"crossref","unstructured":"Bajaj J, Diaz E, Reya T (2020) Stem cells in cancer initiation and progression. https:\/\/doi.org\/10.1083\/jcb.201911053.","DOI":"10.1083\/jcb.201911053"},{"key":"10.1016\/j.ctarc.2026.101332_bib0003","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semcancer.2018.08.009","article-title":"Cancer cell plasticity: impact on tumor progression and therapy response","volume":"53","author":"da Silva-Diz","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0004","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/ijc.27961","article-title":"Complexity of cancer stem cells","volume":"132","author":"Sugihara","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101332_bib0005","article-title":"Cancer stem cell markers\u2014clinical relevance and prognostic value in high-grade serous ovarian Cancer (HGSOC) based on the cancer genome atlas analysis","volume":"24","author":"I\u02d9 Zycka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101332_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0638-3","article-title":"Ovarian cancer stem cells: still an elusive entity?","volume":"16","author":"Lupia","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101332_bib0007","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.3390\/ijms22105059","article-title":"Therapeutic strategies for targeting ovarian cancer stem cells","volume":"22","author":"Yang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101332_bib0008","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/path.5356","article-title":"ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR\/mTOR-PI3K\/aurora kinase inhibitors","volume":"250","author":"Kaipio","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0009","doi-asserted-by":"crossref","unstructured":"Al-Alem LF, Pandya UM, Baker AT, et al. (2019) Ovarian cancer stem cells: what progress have we made? https:\/\/doi.org\/10.1016\/j.biocel.2018.12.010.","DOI":"10.1016\/j.biocel.2018.12.010"},{"key":"10.1016\/j.ctarc.2026.101332_bib0010","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3390\/ijms24032400","article-title":"The prognostic value of cancer stem cell markers (CSCs) expression\u2014ALDH1A1, CD133, CD44\u2014For survival and long-term follow-up of ovarian cancer patients","volume":"24","author":"Izycka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101332_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3904645","article-title":"Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells","volume":"2019","author":"Vassalli","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.ctarc.2026.101332_bib0012","article-title":"Dissecting SOX2 expression and function reveals an association with multiple signaling pathways during embryonic development and in cancer progression","volume":"1879","author":"Niharika","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101332_bib0013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene \u2014 the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110536","article-title":"BMI-1 regulates DNA end resection and homologous recombination repair","volume":"38","author":"Fitieh","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ctarc.2026.101332_bib0015","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/MCB.00981-10","article-title":"BMI1 is recruited to DNA breaks and contributes to DNA damage-induced H2A ubiquitination and repair","volume":"31","author":"Ginjala","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0016","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1083\/jcb.201003034","article-title":"BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair","volume":"191","author":"Ismail","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0017","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.3390\/ijms23158231","article-title":"The crucial roles of Bmi-1 in cancer: implications in pathogenesis, metastasis, drug resistance, and targeted therapies","volume":"23","author":"Xu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101332_bib0018","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2559.2006.02412.x","article-title":"Observer variation in immunohistochemical analysis of protein expression, time for a change?","volume":"48","author":"Kirkegaard","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.ctarc.2026.101332_bib0019","unstructured":"ACD a Biotechne brand (2024) In situ hybridization methods and materials | ACD. https:\/\/acdbio.com\/ebook\/introduction\/materialsmethod. Accessed 18 Oct 2024."},{"key":"10.1016\/j.ctarc.2026.101332_bib0020","doi-asserted-by":"crossref","DOI":"10.2196\/27633","article-title":"Web-based Survival analysis tool tailored for medical research (KMplot): development and implementation","volume":"23","author":"L\u00e1nczky","year":"2021","journal-title":"J. Med. Internet. Res."},{"key":"10.1016\/j.ctarc.2026.101332_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01280","article-title":"Cancer stem cells\u2014origins and biomarkers: perspectives for targeted personalized therapies","volume":"11","author":"Walcher","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.601512","article-title":"c-MYC and epithelial ovarian cancer","volume":"11","author":"Reyes-Gonz\u00e1lez","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0023","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00018-013-1426-x","article-title":"Polycomb group proteins and MYC: the cancer connection","volume":"71","author":"Benetatos","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ctarc.2026.101332_bib0024","first-page":"1","article-title":"Emerging roles of Myc in stem cell biology and novel tumor therapies","volume":"37","author":"Yoshida","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101332_bib0025","doi-asserted-by":"crossref","unstructured":"Yang G-F, He W-P, Cai M-Y, et al. (2010) Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma.","DOI":"10.1186\/1471-2407-10-133"},{"key":"10.1016\/j.ctarc.2026.101332_bib0026","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.anndiagpath.2013.11.004","article-title":"Immunohistochemical expression and prognostic relevance of bmi-1, a stem cell factor, in epithelial ovarian cancer \u2606","volume":"18","author":"El Hafez","year":"2014","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0027","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/IGC.0000000000000024","article-title":"Molecular portraits of heterogeneity related to cancer stem cells in Human ovarian cancer","volume":"24","author":"Zeng","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101332_bib0028","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2026.101332_bib0029","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.gendis.2015.04.001","article-title":"Bmi-1: at the crossroads of physiological and pathological biology","volume":"2","author":"Bhattacharya","year":"2015","journal-title":"Genes. Dis."},{"key":"10.1016\/j.ctarc.2026.101332_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104456","article-title":"Polycomb repressor complex 1 (PRC1) in ovarian cancer: a scoping literature review","volume":"202","author":"Floyd","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0031","article-title":"Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS. One"},{"key":"10.1016\/j.ctarc.2026.101332_bib0032","first-page":"1","article-title":"Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities","volume":"8","author":"Bateman","year":"2024","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0033","article-title":"Author correction: proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities","volume":"8","author":"Bateman","year":"2024","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.ctarc.2026.101332_bib0034","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/15548627.2016.1147670","article-title":"Inhibition of BMI1 induces autophagy-mediated necroptosis","volume":"12","author":"Dey","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.ctarc.2026.101332_bib0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1535-7163.MCT-17-0574","article-title":"Evaluating the mechanism and therapeutic potential of PTC-028, a novel inhibitor of BMI-1 function in ovarian cancer","volume":"17","author":"Dey","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ctarc.2026.101332_bib0036","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.gendis.2022.02.006","article-title":"Targeting BMI1 mitigates chemoresistance in ovarian cancer","volume":"9","author":"Dey","year":"2022","journal-title":"Genes. Dis."},{"key":"10.1016\/j.ctarc.2026.101332_bib0037","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/cpdd.904","article-title":"Pharmacokinetics and safety of PTC596, a novel tubulin-binding agent, in subjects with advanced solid tumors","volume":"10","author":"Shapiro","year":"2021","journal-title":"Clin. Pharmacol. Drug Dev."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:02:58Z","timestamp":1790913778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":37,"alternative-id":["S2468294226002431"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101332","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High expression of the multifunctional proto-oncogene BMI1 predicts poor outcome in high-grade serous carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101332"}}